|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-2-29
|
|
pubmed:abstractText |
The proper time to commence adjuvant chemotherapy after primary surgery for breast cancer is unknown. An analysis of the International (Ludwig) Breast Cancer Study Group (IBCSG) Trial V at a median follow-up of 11 years suggested that early initiation of adjuvant chemotherapy might improve outcome for premenopausal, node-positive patients whose tumors did not express any estrogen receptor (ER).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BonettiMM,
pubmed-author:Castiglione-GertschMM,
pubmed-author:CoatesA SAS,
pubmed-author:ColleoniMM,
pubmed-author:CollinsJJ,
pubmed-author:GelberR DRD,
pubmed-author:GoldhirschAA,
pubmed-author:HolmbergSS,
pubmed-author:LindtnerJJ,
pubmed-author:MariniGG,
pubmed-author:PriceKK,
pubmed-author:RudenstamC MCM,
pubmed-author:ThürlimannBB,
pubmed-author:VeroneseMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
584-90
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10653873-Adult,
pubmed-meshheading:10653873-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10653873-Breast Neoplasms,
pubmed-meshheading:10653873-Chemotherapy, Adjuvant,
pubmed-meshheading:10653873-Cisplatin,
pubmed-meshheading:10653873-Disease-Free Survival,
pubmed-meshheading:10653873-Drug Administration Schedule,
pubmed-meshheading:10653873-Female,
pubmed-meshheading:10653873-Fluorouracil,
pubmed-meshheading:10653873-Follow-Up Studies,
pubmed-meshheading:10653873-Humans,
pubmed-meshheading:10653873-Methotrexate,
pubmed-meshheading:10653873-Premenopause,
pubmed-meshheading:10653873-Proportional Hazards Models,
pubmed-meshheading:10653873-Randomized Controlled Trials as Topic,
pubmed-meshheading:10653873-Receptors, Estrogen,
pubmed-meshheading:10653873-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group.
|
|
pubmed:affiliation |
European Institute of Oncology, Milan, Italy. marco.colleoni@ieo.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Meta-Analysis
|
